VSTR a penny of interest in that being bankrolled by founders of some big internet companies...

 

 

Focus:

 

 

didn't check into ih link yet however...

Detailed Quote for VALUESETTERS INC (VSTR) $ 0.01   0.0007 (+7.53%) Volume: 242.91k 11:13 AM EDT Aug 12, 2014 Today 5d 1m 3m 1y more Last Price 0.01 Change $  0.0007 Change %  7.53% Tick N/A Bid N/A Bid Size 0 Ask N/A Ask Size 0 Open 0.0097 High 0.01 Low 0.009 Prev Close 0.0093 Last Trade 11:13 Volume 242.91k 52 Wk Hi 0.045 52 Wk Low 0.006 Market Cap 5m Ex-Div Date N/A Div Rate N/A Yield N/A Shares 500,000,000 EPS (TTM) N/A PE Ratio N/A Exchange OTCQB

News and Media for VALUESETTERS INC (VSTR) Sector News | Topic News News for VALUESETTERS INC (VSTR) Tue, Jul 08, 2014 10:04 AM Valuesetters Takes Position in the Zelgor Game App - Accesswire Mon, Jun 30, 2014 9:01 AM V-Star Mobile VoIP Calling App Now Available on Google Play - Accesswire Mon, Jun 09, 2014 10:43 AM Valuesetters Acquires a Minority Interest in NetCapital - Accesswire Mon, May 12, 2014

$VSTR. Founders of Netflix, Napster, Atari and MySpace http://investorshub.advfn.com/boards/read_msg.aspx?message_id=103010005 … #OTC:QB:

 

 

 

 

 

Examining a mj outperformer....keeps taking out 52wk highs.

 

tailed Quote for Med-Cannabis Pharma Inc. (MCPI)
$ 0.9375   0.0975 (+11.61%) Volume: 97.94k

   

 

 

 

 

 

MAXD pullback much more contained (at least at this point) then would have thought on the news...

Tue, Aug 12, 2014
8:50 AM	Max Sound Corporation Files Two Lawsuits Against Google, Accusing Search Giant of Stealing Proprietary Technology - Marketwired

 

Detailed Quote for MAX SOUND CORPORATION (MAXD)
$ 0.1952   -0.0148 (-7.05%)

 

etailed Quote for MAX SOUND CORPORATION (MAXD)

$ 0.1952

-0.0148 (-7.05%)

Volume: 410.1k

11:00 AM EDT Aug 12, 2014

 

 

 

 

 

 

 

 

 

 

 

CONX Retesting .35

 

 

Notable earnings after today's close: CHMI, CREE, EPAY, FMI, FOSL, FTD, HMIN, JDSU, JKHY, KING, MYGN, OTC:OPWR, PE, PRSS, SYNC, TCX, URS, VSAT

 

 

USAC among better responses to earnings, although seems as if earnings leak...

 

 

Tue, Aug 12, 2014
6:00 AM	USA Compression Partners, LP Reports Second Quarter 2014 Results, Achieves Record Revenues, Adjusted EBITDA and Adjusted Distributable Cash Flow; Confirms 2014 Outlook - Business Wire
Thu, Jul 24, 2014
4:17 PM	USA Compression Announces Broker Participation Available in Distribution Reinvestment Plan -Business Wire
4:13 PM	USA Compression Partners Announces Fifth Consecutive Quarterly Distribution Increase since IPO; Second Quarter 2014 Earnings Release and Conference Call Scheduled for August 12 - Business W

 

 

 

 

As we examine ICPT pullback...

 

Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic

WHITEFISH, MT / July 24, 2014 / Fat is driving the bus these days in one narrow, but widening, biotech sector as companies strive for dominance. Among these are Galectin Therapeutics Inc. (NASDAQ: GALT), Intercept Pharmaceuticals (NASDAQ: ICPT), Raptor Pharmaceuticals (NASDAQ: RPTP) and Gilead Sciences (NASDAQ: GILD), all of which are in search of a cure for one stage or another of "fatty liver disease." 

Fatty liver disease, at its extreme, means certain death. The prize these companies are seeking is not only to cheat death but also to claw back some of the astronomical healthcare costs related to the condition. Taking into account the varying stages of fatty liver disease, the U.S. market is projected to be valued at up to $40 billion by 2025. There's always the liver transplant option, right? Wrong. One estimate, from TransplantLiving.org, places the cost of a liver transplant at nearly $600,000 and that estimate does not even cover all the other healthcare costs on the long road to referral for a transplant. For the half a million people in the U.S. that have liver cirrhosis or the up to 15 million people suffering from fatty liver disease, the hope for a transplant is not good either, considering only about 6,300 liver transplants are conducted annually. 

Worse yet, diagnostics outside of a biopsy are lacking and there are no FDA approved therapies for the treatment of liver fibrosis, which explains the value Wall Street is placing on this relatively unattended segment of biotech. 

Medical terms for these related diseases and their stages vary. NAFLD is a catch-all term meaning nonalcoholic fatty liver disease (estimated to affect about 30% of the North American population); NASH refers to nonalcoholic steatohepatitis, a condition which, according to a statement at Science.gov, "can progress to cirrhosis in 15-20%" of patients. The statement goes on to show that NAFLD "may predispose patients to hepatocellular carcinoma," i.e., liver cancer. The U.S. National Institutes of Health notes that "NASH occurs in people who drink little or no alcohol and affects 2 to 5 percent of Americans, especially people who are middle-aged and overweight or obese," and that the condition also occurs in children. 

From a clinical stage perspective, Intercept is leading the race, having delivered positive data from a Phase 2 trial of obeticholic acid (OCA) earlier this year. Shares tripled on the news. Galectin, a newly-coined member of the Russell 2000, is nipping at Intercept's heels and actually may be closer than what first appears with a Phase 1 trial because of the potential to treat fatty liver disease even once it has progressed. What distinguishes their approach from others that the timing of intervention with their proprietary carbohydrate polymer drug GR-MD-02 may be largely irrelevant to outcomes, with GR-MD-02 seeming to work well even in advanced stages of liver fibrosis. This is especially important in fatty liver diseases because they are silent killers, often going undiagnosed for many years. The Galectin drug was granted FDA fast-track approval nearly a year ago. 

 

 

Galectin has announced GR-MD-02 to be safe and well tolerated in the first cohort of patients in its clinical trial, as well as showing changes in key biomarkers, which suggests a therapeutic effect on fibrosis, or scarring of the liver that leads to loss of liver function. Enrollment has been completed in the second cohort, with results expected in the next few weeks, potentially a catalytic moment for the company's value. 

Further, late in June Galectin disclosed that research in an animal model of NASH showed an oral version of GR-MD-02 to demonstrate a significant improvement in disease. Coming at NASH with both infused and oral formulations could give Galectin a competitive edge going forward. 

Raptor has been narrowly focused on NASH treatment of adolescents with a slow-release form of cysteamine bitartrate, which it developed after obtaining rights to the core drug from University of California at San Diego. Raptor is conducting a Phase 2b trial under a Cooperative Research and Development Agreement with the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health. 

Gilead is acting across a broader age spectrum in NASH treatment and should be completing enrollment soon for a Phase 2b testing of its drug simtuzumab (GS-6624). Results might be announced late 2016 or so. Gilead is looking to grow its footprint in the liver disease space that is being overrun by NASH diagnoses. The growing number of effective treatments for hepatitis C, including Gilead's Sovaldi, are lending to a stabilized number in liver transplants related to hep C, with predictions that NASH will surpass hep C as the leading cause of liver transplants by 2020. 

The apparently sudden prevalence of fatty liver disease and NASH on the biotech horizon is due to the increasing incidence of obesity worldwide and greater awareness of the conditions. After all, NASH didn't even have a medical name three decades ago. A U.S. Centers for Disease Control reportsays that 34.9% of American adults are obese. That's a 50% increase in obesity in less than 40 years and has lent impetus to the rise in NASH, a disease dubbed "the next big global epidemic" on CNBC's NBR. 

Those are big numbers and potentially big profits. So it is clear that fat is indeed driving the biotech bus, with Galectin, Intercept, Gilead and Raptor in the front seats and vying to take control of the wheel.

Click here to receive free email updates on Galectin Therapeutics' developments: http://www.tdmfinancial.com/emailassets/galt/galt_landing.php 

 

 

 

 

PROP lands major deal on its breakthrough plasma related, micro fracking technology. Analyst calling it a game changer / predicts explosion in stock similiar to his call on Flotek in 2010,

 

Focus stock:  PROP   Last .24

 

Examining a recent, quite significant deal with PROP in addition to bullish article issued by NBT Equities.

 

First, the company pr:

Propell Technologies to Treat Two Wells on Miller Energy's Appalachian Basin with Next Generation Plasma Pulse ToolGlobeNewswire(Wed, Aug 6)

 

"We are looking forward to working with Miller Energy with the new U.S. made tools. We believe that this certainly opens up the market for us and we anticipate ordering several additional tools shortly thereafter," stated CEO John Huemoeller II.

 

 

Aside from this new US deal, over 150 companies have utilized Novas Plasma Pulse Technology in the treatment and stimulation of oil wells throughout the Russian Federation, China, Kazakhstan, Uzbekistan and Czech Republic.

 

 

In addition to the company pr, a separate report was also issued by NBT Equities that contains some quite compelling information on the stock worth reviewing:

 

 http://www.nbtequitiesresearch.com/company/propell-technologies-group-inc-prop/report/nbt-equities-research-initiating-coverage-on-propel-technologies-group-inc-prop

 

In particular it cites Propell Technologies Group, Inc. (PROP) as game changer in the oil industry / huge ground floor opportunity. 

 

Below is a portion of the report:

 

This next-generation oil fracking technology has proven it can add $170 million to $340 million per DAY in new US oil production...and turn this tiny energy services company into the next $billion energy tech giant

If you missed the $billions made from the first fracking technology stock boom stocks like:

5,557% gain in 35 months in Kodiak Energy (KOG)

1,372% gain in 22 months in Northern Oil and Gas (NOG)

3256% gain in Brigham Exploration in 28 months (BEXP)

Don't miss the NEXT $Billions to be made in the American Oil Technology Revolution: Micro-Fracking from Propell Technologies (PROP)

---

Dear Wealth Seeking Investor,

Let's face it: achieving life-changing wealth in the 21st century is every investor's dream.

For many investors, when they think about where the greatest wealth has been created recently in the United States, they think Silicon Valley...San Franciso.

And they would be right. Recent studies of wealth creation in the first decades of the 21st century from the fine research folk at Wealth Insight shows that 2.07% of every resident of San Francisco is indeed a millionaire (>$1 million of assets outside of the value of their home).

But what is MOST fascinating to me about this recent report—and MOST important to my special report today is "What major city in the United States OTHER than New York City—8 TIMES the population of San Francisco—has MORE millionaires per capita than San Francisco?

Did you guess...

... "Houston Texas?"

If you did, you're right. According to the Wealth Insight report 2.09% of Greater Houston's 6.4 million residents is a millionaire. And what new innovation/revolution created most of these new millionaires?

The Shale Energy revolution of course...created by the revolutionary oil producing technologies of 1) horizontal drilling and 2)hydraulic fracturing or "fracking".

Sorry Mark Zuckerberg or Elon Musk: it's a fact. FAR more billionaires and millionaires have been created in America from the Shale Energy Revolution and its amazing technology than all the Social Media/Cloud/Big data technology wealth combined.

Now the question is...are you ready to make your fortune from the energy technology revolution in America?

Great—let's get started on YOUR path to wealth.

In the next few minutes I am going to make the case that THIS company is indeed one of the next millionaire makers in the energy technology miracle that I've come to call "Saudi America."

Welcome to Saudi America...where the United States is fast replacing Saudi Arabia as the world's biggest oil producer.

Opportunity IS all around you...and yes fortunes ARE being made daily in Saudi America.

But our story today is about a revolutionary technology that brings the miracle of fracking technology to the billions of barrels of oil that already EXIST in America.

I believe shareholders in this company stand to make the same kind of money early investors made in another little energy technology company I discovered in 2010.

That company is Flotek Industries (FTK)—it's a fracking technology company—and its price chart tells a most compelling story of how a tiny Houston based company created thousands of millionaires from its energy fracking services technology.

Fast forward to today.

Propell Technologies...through its subsidiary Novas Energy...has exclusive rights to a similar game-changing technology to FloTek that has NOTHING to do with finding or extracting new oil deposits.

The Novas Plasma-Pulse enhance oil recovery technology allows owners of the 420,000 EXISTING oil wells in the United States—specifically the ones producing less that 10 barrels a day—to double, triple and sometime gain up to 10 times the production from their existing wells.

.....

Summary: 10 Compelling Reasons Why PROP is a STRONG Buy TODAY under 50-60 Cents

1. PROP's Plasma-Pulse patented technology has been 100% successful in 200+ marginal oil wells worldwide increasing production at LEAST 175% over pre-treatment existing production (source: PROP data)
2. The total U.S. market for re-activation/enhanced production of low/no production oil wells is +550,000 stripper, injection and shut-in wells (source: United States Energy Information Agency (EIA)
3. After drilling 2.6 million oil wells, over 50% of ALL the oil EVER discovered in the United States remains unrecovered and still in the ground (source: EIA)
4. 45,000 NEW oil wells are projected to be drilled in the next 5 years in the United States (source: EIA)
5. 150 oil companies—6 majors—have tested and proved PROP's Plasma-Pulse technology SAFE (source: Novas Energy website)
6. PROP just introduced an American made 2.0 verion of its Plasma-Pulse tool which can treat 4.5" cases wells which represent the vast majority of US vertical wells. Since the original tool was too large to treat these 4.5" wells, significant new revenues are now available to PROP.
7. Plasma-Pulse Micro-fracking is 100% Environmentally SAFE vs. Hydro-Fracking (source: Novas Energy website)
8. Plasma-Pulse Micro-fracking is up to 95% LESS costly than hydro-fracking existing wells (source: NBT estimate)
9. Near term elimination of ALL PROP convertible debt will reduce downward pressure on the stock
10. Our price target for PROP is 8-10X HIGHER than today's price for PROP

for more:   http://www.nbtequitiesresearch.com/company/propell-technologies-group-inc-prop/report/nbt-equities-research-initiating-coverage-on-propel-technologies-group-inc-prop

 

 

 

 

In addition to 8/6 news, there are other signs this technology is about to get discovered as they have recently beefed up their staff, in addition to presenting at various....

• Propell Technologies Announces the Addition of Trent Hunter as Chief Technology OfficerGlobeNewswire(Tue, Jul 29)
• PROPELL TECHNOLOGIES GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale ofEDGAR Online(Thu, Jul 3)
• Propell Technologies to Exhibit Its Plasma Pulse Oil Well Stimulation Process at Global Hunter Securities June Energy Conference in ChicagoGlobeNewswire(Tue, Jun 17)
• Propell Technologies to Take Delivery of Next Generation Well Stimulation Tool in JuneGlobeNewswire(Thu, Jun 12)

Milestone Expected to Result in Larger Addressable Market, Easier Operation and Greater Compatibility with US Wireline Configurations.

.....the company expects to be able to treat the estimated 1 million US vertical and directional wells in its market as opposed to onlqy those with 5.5" casings, estimated to be about half of those in the US. 

"With this next gen tool we should be in a position to treat most any vertical well in the country using any wireline truck. Until now we've had to turn away opportunities to treat otherwise ideal wells due to undersized well casings and wireline incompatibility," stated CEO John Huemoeller II. "This is a milestone that we expect to provide significantly greater revenue and profitability going forward."

 

 

 

 

Technically, the stock closed essentially flat yesterday, however did witness a volume pickup.

In addition, has been seeing ongoing support near current levels:

 

 

 

Bottom line:  PROP is beginning to bear fruit on a true game changing technology within the oil industry.  Combined with ongoing support near current levels, the risk reward ratio is quite appealing.  As a result, look for a pickup developin on this stock into late summer/fall.

 

 

 

 

 

 

 

Disclosure:   Greenbackers does receive compensation from NfBT Equities from time to time to assist in expanding awareness for companies they initiate coverage on.  This includes PROP.

 

 

 

Greenbackers will use reasonable efforts to include accurate and up-to-date information on this website but makes no representations, warranties or assurances of any kind as to the accuracy, currency or completeness of information. Access to and use of the content is at your own risk, and neither Greenbackers. nor any party involved in creating, producing, or delivering this site shall be liable for any damage of any kind arising out of, or resulting from, your access to, use of or inability to access or use this website, any omissions or errors in its content, or from your reliance on any information provided at this website.

© Copyright Greenbackers.com Inc 2014
All Rights Reserved
Greenbackers.com is a service mark of Greenbackers

 

 

 

 

To unsubscribe, reply to email with 'unsubscribe' in subject line.

Nutritional Beverage play KRED announces today that sales are expected to double. Deals have been relentless in 2014, including Walmart and Kroger stores....pps bumping up as we speak .37

 

KRED announcing bullish projections in a company press release today

 

Worth examining a little closer, especially with all the deals that keep coming.

 

In addition to all the deals, the stock has been beaten down undeservedly as there's been nothing but good news year long, including all the deals this last quarter alone.

 

• KonaRed Corporation Adds Retail Locator To Make Finding Products Easy!PR Newswire(Fri, Aug 1)
• KonaRed Expands into New York City Metro AreaPR Newswire(Thu, Jul 24)
• KonaRed Increases Sales and Retail Placements via Splash Beverage GroupPR Newswire(Mon, Jul 21)
• KonaRed Continues Marketing Initiatives with Key Sponsorship AnnouncementsPR Newswire(Tue, Jul 15)
• KonaRed Corporation Presents: 'The Story Behind Our Products'Marketwired(Mon, Jun 30)
• KonaRed Corporation Forms Strategic Alliance with Sparkling Drink Systems InternationalPR Newswire(Thu, Jun 19)
• KonaRed Is Featured In Major Article In Key Beverage Industry PublicationPR Newswire(Tue, Jun 17)
• KonaRed Corporation Products Now Featured in More Than 50 Fred Meyer StoresPR Newswire(Thu, Jun 12)
• KonaRed Corporation Raises First $500,000 from $12 Million Equity LinePR Newswire(Mon, Jun 2)
• KonaRed Corporation Adds Nature's Best as New CustomerPR Newswire(Thu, May 29)

 

 

$ 0.3749

0.0037 (+1.00%)

Volume: 187.57k 1:39 PM EDT Aug 6, 2014

 

 

KonaRed Corporation (KRED)

-Other OTC

0.36  0.01(3.02%) 1:14PM EDT

 

Volume:	170,621
Avg Vol (3m):	192,627
Market Cap:	27.19M

 

 

 

 

 

 

 

 

Release #:812-143355-em-1159943:

KonaRed Explains Why Sales Doubling KonaRed Corporation CEO Interviewed on CEOLIVE.TV -- Doubling Sales in 2014 Through Major Retail Chains in U.S. --   [06-August-2014]     KOLOA, Hawaii, Aug. 6, 2014 /PRNewswire/ -- KonaRed Corporation (OTCBB/OTCQB: KRED), (www.konared.com) manufacturers of Antioxidant Juices from the world famous Hawaiian CoffeeBerry®, coffee fruit from Kona, Hawaii, said that its co-founder, CEO and Chairman Shaun Roberts was interviewed by CEOLIVE.TV as part of its Executive Interview Series. The entire interview is available at http://ceolive.tv/konared-corp/kred-videos/2270-ceolive-tv-interview-shaun-roberts-ceo-of-konared-corp . In the interview, Shaun Roberts, Founder, CEO and President, details the attributes of the Hawaiian CoffeeBerry® coffee fruit from Kona, Hawaii, explaining the story behind the KonaRed products. He also says that KonaRed's push to expand its distribution network is on track and is expected to double sales in 2014. Driving these sales upward are the successful efforts of its strategic partner, Splash Beverages, to continue to recruit major distributors and retail chains throughout the U.S. as customers of KonaRed. "Our campaign of using in store product demonstrations, which hand out a free 2oz. taste sample in the major grocery stores, is a key to increasing sales," Mr. Roberts told Mike Elliott of CEOLIVE.TV. "I'm confident in achieving our sales goals as once you try it, you will buy it." KonaRed products are sold in select Kroger locations, Ralphs, Fred Meyer, Vitamin Shoppe, Whole Foods, Safeway, Walmart, 7-Eleven, and many other retail outlets throughout the U.S. and Canada. "We now have three products being displayed on store shelves, original, green tea, and coconut water. Three is a magic number in retailing and is giving us the profile we need to capture consumer interest," Mr. Roberts concluded. About CEOLIVE.TV CEOLIVE.TV is an online financial news portal focused on small cap publicly traded companies with a focus on undervalued stocks. Featuring short video interviews with CEOs, CFOs, Board Members and other corporate executives, CEOLIVE.TV gives investors the opportunity to learn about companies directly from the management team as well as access to detailed company profiles, video press releases and sector reports. To learn more, please visit www.ceolive.tv. About KonaRed Corporation KonaRed Corporation produces health and wellness nutritional products including beverages and supplements, which bring the attributes of Hawaiian Coffee fruit to an international consumer market. We established our business in August, 2008 and achieved our first sales in February, 2009. In October, 2013 KonaRed went public on the OTCBB/OTCQB trading under the symbol KRED. KonaRed, through a licensing agreement with VDF FutureCeuticals, Inc., utilizes innovative, state of the art, proprietary processes that produce antioxidant extracts and powders from Hawaiian Coffee Fruit, which are used to produce KonaRed's Antioxidant Juices, Organic Green Teas, and On-the-Go Packs. KonaRed Corporation is headquartered in Koloa, Hawaii, and its distribution center is in San Clemente, California. Forward Looking Statements Certain information contained in this press release, including any information as to our strategy, plans or future financial or operating performance and other statements that express management's expectations or estimates of future performance, constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Action of 1934. All statements, other than statements of historical fact, are forward-looking statements. The words "believe," "expect," "will," "anticipate," "contemplate," "target," "plan," "continue," "budget," "may," "intend," "estimate," "project" and similar expressions identify forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to its plans or operations. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the SEC which can be found at www.sec.gov. There may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. For Investor and Media Inquiries, please contact: KonaRed Corporation Investor Relations E and E Communications Paul Knopick Email: pknopick@eandecommunications.com Tel 940.262.3584 Logo - http://photos.prnewswire.com/prnh/20140617/119162 SOURCE KonaRed Corporation   Photo: http://photos.prnewswire.com/prnh/20140617/119162 Web Site: http://www.konared.com

My EANDE More Information

Wednesday, August 06, 2014 10:38:12 AM 1159943

 

 

 

 

 

 

 

Technically on the stock, has become oversold on the intermediate term falling from .50 just the last two weeks alone, especially with the fact that there has been nothing but good news, but do notice firming this week.

 

 

 

Source:  http://otcbb.com/asp/Info_Center.asp

 

 

 

 

Bottom line:  With nothing but good news, including today, combined with the recent, steep 35% slide, we're seeing a quite appealing risk/reward ratio at current levels.  Should be highly debated for near term snapback near term / turnaround into the month.

 

 

 

 

 

 

 

 

Disclosure:   Greenbackers received a one day compensation from a third party to assist with expanding awareness on KRED

 

 

 

Greenbackers will use reasonable efforts to include accurate and up-to-date information on this website but makes no representations, warranties or assurances of any kind as to the accuracy, currency or completeness of information. Access to and use of the content is at your own risk, and neither Greenbackers. nor any party involved in creating, producing, or delivering this site shall be liable for any damage of any kind arising out of, or resulting from, your access to, use of or inability to access or use this website, any omissions or errors in its content, or from your reliance on any information provided at this website.

© Copyright Greenbackers.com Inc 2014
All Rights Reserved
Greenbackers.com is a service mark of Greenbackers